Jessica M. Stempel
@jmstempel
Heme/Onc fellow @Yale @YaleHemOnc l @ASH_hematology Trainee Council 2022-2024 l @EinsteinHealth IM resident/chief l MD-UCV 🇻🇪 - views are my own
ID: 1396844859282108419
24-05-2021 15:07:11
166 Tweet
235 Followers
264 Following
Check out our research paper on the clinical and molecular features of extramedullary AML Leukemia Journal. Grateful for the amazing co-authors Cleveland Clinic. Carmelo Gurnari Waled Bahaj, MD Olisaemeka Ogbue, MD Hetty Carraway Valeria Visconte doi.org/10.1038/s41375…
Grateful for the opportunity to join this phenomenal group of current & future leaders of #cancer research at the ASCO AACR #MCCR #VailWorkshop. Huge thanks🙏🏼to all the organizers & faculty esp patient advocates. Shoutout to the best PDG-12!! #mssm Myeloma Society Multiple Myeloma RF
Amer Zeidan MBBS,MHS عامر زيدان Yale School of Medicine Abdulrahman Alhajahjeh, MD Wondering why so many clinical trials end prematurely? Our latest research digs into this critical issue. This work would not have been possible without such an excellent team Abdulrahman Alhajahjeh, MD Jessica M. Stempel Amer Zeidan MBBS,MHS عامر زيدان Maximilian Stahl Jan Bewersdorf...Yale IM Traditional Residency Program YaleMedPSTP
It was a pleasure to participate in this rapid mentoring sessions! Always happy to contribute even with encouraging words in the journey of the next generation of hematologists ❤️ Kelly Meza, MD Mary Cushman 🫀🧠🩸 Andres Gomez Jessica M. Stempel #mentoring #ASHEducation #ASH24
.Jessica M. Stempel & Dr. Nikolai Podoltsev share research demonstrating that Calcineurin Inhibitor + Eltrombopag is effective in reducing transfusion requirements for patients w acquired #AplasticAnemia. #ASH24 Smilow Cancer Hospital Yale Hematology Oncology Fellows YaleHematology OncoAlert
Beautiful run! Jessica M. Stempel Natalia Neparidze YaleHematology Yale Hematology Oncology Fellows #ASH24 #ASH5K
An overview of treatment patterns & outcomes of CAR-T & Bispecific T-Cell Engager BiTE therapies in Relapsed/Refractory #MultipleMyeloma from Smilow Cancer Hospital Yale Cancer Center, presented by Poy Theprungsirikul, MD Yale Hematology Oncology Fellows #ASH24 Natalia Neparidze YaleHematology
.Kunal Potnis, MD reveals that at the current pricing, eltrombopag plus traditional immunosuppressive therapy is unlikely to be a cost-effective treatment for adults with severe aplastic anemia in the US. #ASH24 George Goshua, MD MSc YaleHematology Smilow Cancer Hospital ash.confex.com/ash/2024/webpr…
Incredible work by Abdulrahman Alhajahjeh, MD !!
Excited to share our work! Thank you Amer Zeidan MBBS,MHS عامر زيدان Rory M. Shallis, MD for your mentorship and support!
Dr Luca Lanino Yale Cancer Center Humanitas Milano presenting an excellent project that developed a molecular classification & a new, independently validated, risk stratification tool that outperformed all the other available for #CMML in collaboration with GenoMed4All International Consortium for MDS (icMDS)
Celebrating Dr. Jennifer Afranie-Sakyi, Yale Hematology Oncology Fellows, and her presentation of implementation rates of the ASH cerebrovascular guideline screening for silent cerebral infarct and cognition in #sicklecelldisease #SCD at #ASH24! Dr Cece Calhoun YaleHematology
Dr. Nikolai Podoltsev presents ECOG-ACRIN Cancer Research Group E1910 Ph III trial of the addition of Blinatumomab to consolidation therapy for older, newly diagnosed patients with BCR::ABL1 negative B-Lineage Acute Lymphoblastic Leukemia #ALL #ASH24 with Selina Loger, MD Penn Medicine - Abramson Cancer Center & Mark Litzow
Drs Melissa Taylor and Devora Isseroff Yale Hematology Oncology Fellows Yale Cancer Center #sabcs24 #bcsm
